Literature DB >> 29174267

Coronary artery disease in women.

Nainar Madhu Sankar1, Salla Sweta Ramani2, Rajaram Anantharaman3.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 29174267      PMCID: PMC5717312          DOI: 10.1016/j.ihj.2017.10.008

Source DB:  PubMed          Journal:  Indian Heart J        ISSN: 0019-4832


× No keyword cloud information.
Dear Editor, In the recent article titled, ‘Coronary artery disease in women’, Dr. Pathak LA et al., has elucidated well on sex specific morbidity of coronary artery disease in women. While we appreciate the authors’ commendable work for their extensive 6 year research in women, we would like to add few comments. In the current decade, worldwide there is an increase in the number of women undergoing coronary artery bypass grafting (CABG). This is a surrogate marker of the fact that CAD in women is recognised more often and much earlier than in previous years. This has been reflected in our data. We compared two groups of women undergoing CABG – group I (1998–2002; n = 293) and group II (2010–2014; n = 395). There was an increase from 11% of the total number of female patients who underwent CABG from Group I to 19.5% from Group II. The mean age is higher and there was increase in the percentage of women having previous PCI in group II. Despite the increase in severity of disease and comorbid conditions, improved outcomes were observed.

Conflicts of interest

None.

Source of funding

None.
  2 in total

1.  The Women's Ischemia Syndrome Evaluation (WISE) study: protocol design, methodology and feasibility report.

Authors:  C N Merz; S F Kelsey; C J Pepine; N Reichek; S E Reis; W J Rogers; B L Sharaf; G Sopko
Journal:  J Am Coll Cardiol       Date:  1999-05       Impact factor: 24.094

2.  Coronary artery disease in women.

Authors:  Lekha Adik Pathak; Salil Shirodkar; Ronak Ruparelia; Jaideep Rajebahadur
Journal:  Indian Heart J       Date:  2017-06-12
  2 in total
  1 in total

1.  Fluvastatin inhibits cardiomyocyte apoptosis after myocardial infarction through Toll pathway.

Authors:  Lili Jia; Liang Wang; Wenxue Liu; Guanglei Qian; Xiufang Jiang; Zhimian Zhang
Journal:  Exp Ther Med       Date:  2018-06-13       Impact factor: 2.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.